Xia, Eric
Gaurav, Ahana
Yan, Allison
Mostaghimi, Arash
Article History
Accepted: 4 November 2023
First Online: 18 November 2023
Compliance with Ethical Standards
:
: This project is exempt from Mass General Brigham IRB Review.
: Dr. Mostaghimi has received consulting fees from Pfizer, hims, Digital Diagnostics, Concert, Lilly, and AbbVie as well as licensing/royalties from Pfizer and Concert; holds equity in and is on the advisory board for hims and Figure 1; and has participated in clinical trials related to alopecia from Incyte, Lilly, Concert, and Aclaris while serving as associate editor for JAMA Dermatology. No other conflicts of interest were reported.
: This article does not contain any studies with human or animal subjects performed by any of the authors.